Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Clinical and Translational Research Unit (CTRU) Palo Alto, California, United States
  • Lucile Packard Childrens Hospital Palo Alto, California, United States
  • University of California, San Francisco - Outpatient Hematology Clinic San Francisco, California, United States
  • Stanford Health Care Stanford, California, United States
View all 75 locations
View Trial Details
Completed

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

NCT03061201

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • City of Hope Medical Center Duarte, California, United States
  • Midtown Ambulatory Care Center Sacramento, California, United States
  • UC Davis Ambulatory Care Clinic Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)

NCT04770935

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • University of Iowa_Investigational Site Number :8400002 Iowa City, Iowa, United States
  • Hemophilia Center of Western Pennsylvania_Investigational Site Number :8400001 Pittsburgh, Pennsylvania, United States
  • Investigational Site Number :2500001 Lille, France
  • Investigational Site Number :2500002 Nantes, France
View Trial Details
Completed

A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A

NCT04161495

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Investigational Site Number 920 Los Angeles, California, United States
  • Investigational Site Number 921 Los Angeles, California, United States
  • Investigational Site Number 911 San Diego, California, United States
  • Investigational Site Number 917 Gainesville, Florida, United States
View all 47 locations
View Trial Details
Completed

A Study of BAX 888 in Male Adults With Severe Hemophilia A

NCT03370172

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
View all 26 locations
View Trial Details

Related conditions